|
2008 NanoBusiness Conference
|
|
Keynotes -- NanoBusiness 2007
• Norbert Riedel
• Terry Taber
• Josh Wolfe
• Scott Livingston
• Sean Murdock
• Senator John Kerry
|
 |
Senator John Kerry
Chairman, Senate Committee on Small Business and Entrepreneurship
John Kerry was elected Lieutenant Governor in 1982. In that office, he organized the nation's Governors to combat the acid rain that was polluting lakes, rivers, and the nation's water supply. Two years later, he was elected to the United States Senate and he has won reelection three-times since. He is now serving his fourth term, after winning again in 2002 by the largest margin in Massachusetts history.
John Kerry entered the Senate with a reputation as a man of conviction. He confirmed that reputation by taking bold decisions on important issues. He helped provide health insurance for millions of low-income children. He has fought to improve public education, protect our natural environment, and strengthen our economy. He has been praised as one of the leading environmentalists in the Senate, who stopped President Bush’s plan to drill in the Arctic National Wildlife Refuge.
In 2003, John Kerry announced that he would be a candidate for president of the United States -- and he went on to mount a come from behind campaign that won the Democratic nomination. The American people reminded him once again that people are the same wherever you go, and he continues in the United States Senate fighting for what motivated him to enter public life in the first place: love of country and the call of duty. For a more in-depth biography of Senator John Kerry, click here.
Back to Top |
|
Terry Taber
Chief Operating Officer for Image Sensor Solutions, Eastman Kodak
During his 28 years at Eastman Kodak, Terry Taber has been involved in new materials research, product development and commercialization, manufacturing, and business management.
Initially at Kodak, Terry conducted synthetic research on new materials for photographic film applications and holds several patents in this area. After leaving the lab, he was program manager for several Kodak products, including the films and cartridge for the Advanced PhotoSystem launched in 1996. Terry became the worldwide consumer film business product manager from 1999 – 2002. He returned to R&D as an Associate Director from 2002 – 2005, followed by the Director of Materials & Media R&D from 2005 – 2007. Since early 2007, he has been the Chief Operating Officer for Image Sensor Solutions. His range of projects and leadership roles has always involved understanding and combining technologies, products, manufacturing, and customers into a robust business.
Terry received his B.S. degree in Chemistry from Purdue University in 1976 and his Ph.D. in Organic Chemistry from CalTech in 1980. In addition, he received an M.S. in General Management from MIT in 1997, as a Kodak Sloan Fellow.
In 2003, Terry was elected to the Board of Trustees at Roberts Wesleyan College and Northeastern Seminary.
Terry is married (wife, Sherri) with two adult children. He is active in community and church groups and enjoys golf, bicycle riding, and hiking.
Back to Top |
|
Norbert Riedel
Corporate Vice President and Chief Scientific Officer, Baxter International Inc.
Norbert G. Riedel, Ph.D., is corporate vice president and chief scientific officer of Baxter International Inc., having served in that capacity since March 2001. He joined Baxter in 1998 as president of the recombinant unit within Baxter's BioScience business. Prior to joining Baxter, he was head of worldwide biotechnology and core research functions at Hoechst Marion Roussel, now Sanofi-Aventis.
Dr. Riedel received his Ph.D. in biochemistry from the University of Frankfurt in 1983. He was a postdoctoral fellow at Harvard University from 1984 - 1987, assistant professor and associate professor of medicine and biochemistry at Boston University School of Medicine from 1987 - 1991, and a visiting professor at Massachusetts Institute of Technology in 1992. He remains affiliated with Boston University as an adjunct professor and also has an adjunct professor of medicine appointment at Northwestern University Feinberg School of Medicine.
Dr. Riedel serves on the board of directors of Oscient Pharmaceuticals Corporation and Medigene AG. He is currently serving as chairman and member of the executive committee of the board of directors of the Illinois Biotechnology Industry Organization, and is a member of the Advisory Board of The Northwestern University Kellogg School of Management Center for Biotechnology.
Back to Top |
|
Scott Livingston
Managing Director of Axiom Capital Management Inc.
Scott Livingston is a Managing Director of Axiom Capital Management Inc. and heads the Livingston Group, a leading investment banking/advisory group focused on nanotechnology. Axiom Capital Management Inc. provides wealth management, investment banking, prime brokerage and private equity services.
Mr. Livingston has been called “sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, the Delaware Technology Park, the Business Executives for National Security, Hilary Clinton’s Jobs for New York, and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the first annual Axiom Capital Management “Livingston Nanotechnolgy Conference”, one of the largest nanotechnology conferences of the year.
Previously, Scott has served as a Senior Vice President – Investment Management at Lehman Brothers, where he began his nanotechnology focus, and managed more than $150 million in client assets. Prior to joining Lehman Brothers in 2000, Scott was a Director of the Private Client Group at SG Cowen Securities, and prior to that was at Drexel and Smith Barney.
Scott is a SUNY Albany graduate. He is a board member of the NanoBusiness Alliance and a founding board member of the NY Nanobusiness Alliance. Scott sits on the board of the Nanoethics Group and the Dolan DNA Learning Center at the Coldspring Harbor Labs. He is married with three children and lives in Long Island, NY.
Back to Top |
|
Josh Wolfe
Managing Partner, Lux Capital & NbA Co-Founder
Josh Wolfe is a co-founder and Managing Partner of Lux Capital focusing on investments in Nanotechnology. Before forming Lux Capital, he worked in Salomon Smith Barney's Investment Banking group, where his experience included a $4 billion hotel merger, and a defense against an unsolicited LBO. Josh has also worked in capital markets while at Merrill Lynch on its Financial Futures & Options/Government Strategy desk and at Prudential Securities in its Municipal Finance department.
Prior to venturing into the financial world, Josh conducted and published cutting edge AIDS/immunopathology research in Cell Vision and The Journal of Leukocyte Biology, leading medical/immunology journals.
Josh graduated with distinction from Cornell University with a B.S. in Economics and Finance. He has been an invited guest speaker, lecturer and panelist on nanotechnology to Harvard, Yale, Wharton, Columbia, Cornell, Merrill Lynch, Capitol Hill, government labs, and officials in France, Canada, UK, Spain and Germany. Josh is a a co-founder of The NanoBusiness Alliance, a Senior Associate of the Foresight Institute for Nanotechnology, the Coordinator for the Institute of Molecular Manufacturing's Prize in Computational Nanotechnology, and a member of the Cognitive Science Society.
Josh is author of the acclaimed "Nanotech Report" and Editor of Forbes' new publication, the "Forbes/Wolfe Nanotech Report."
Back to Top
|
|
Sean Murdock
Executive Director.
NanoBusiness Alliance
Prior to becoming the Executive Director of the NanoBusiness Alliance, he was the Executive Director and a founding board member of AtomWorks, an initiative formed to foster nanotechnology in Illinois and more broadly throughout the Midwest.
Sean has established himself as a leading thinker in the areas of nanotechnology commercialization and economic development. He has delivered keynote speeches on the commercialization of nanotechnology at several nanotechnology conferences, and served as co-chair for the commercialization focused NanoCommerce 2003 conference and trade show. Sean has been quoted extensively on the subject in many leading publications including Fortune, The Economist, the Chicago Tribune, the Chicago Sun-Times, and Small Times.
Sean has been very active in nanotechnology trade and economic development issues. He helped to organize and execute the first Nanotechnology Trade Mission to Europe in conjunction with the NanoBusiness Alliance and the U.S. Department of Commerce. He has also been engaged with senior officials of the U.S. Department of Commerce's Technology Administration on the potential impact of export control issues on nanotechnology development and commercialization.
Prior to founding AtomWorks and serving as the Executive Director of the NanoBusiness Alliance, Sean had more than 7 years experience in management consulting, most recently as Engagement Manager at McKinsey & Company. Sean served a variety of Fortune 500 companies, focusing primarily upon the industrial and chemicals sectors. While there, he developed some of the firm's early perspective on the business opportunities created by the nanotech revolution, publishing the first two internal documents on the subject.
Sean received his Masters in Business Administration and Masters in Engineering Management from Northwestern University. He holds a BA in Economics from the University of Notre Dame.
Back to Top |
|
|
